David Pernock
2019 - Eagle Pharmaceuticals
Compensation breakdown
| Non-Equity Incentive Plan | $681,100 |
|---|---|
| Option Awards | $1,003,778 |
| Salary | $567,582 |
| Stock Awards | $886,160 |
| Other | $33,805 |
| Total | $3,172,425 |
Pernock received $1M in option awards, accounting for 32% of the total pay in 2019.
Pernock also received $681.1K in non-equity incentive plan, $567.6K in salary, $886.2K in stock awards and $33.8K in other compensation.
Rankings
In 2019, David Pernock's compensation ranked 3,853rd out of 13,971 executives tracked by ExecPay. In other words, Pernock earned more than 72.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,853 out of 13,971 | 72nd |
Division Manufacturing | 1,389 out of 5,698 | 76th |
Major group Chemicals And Allied Products | 489 out of 2,197 | 78th |
Industry group Drugs | 413 out of 1,883 | 78th |
Industry Pharmaceutical Preparations | 314 out of 1,395 | 78th |
Pay ratio
| David Pernock's Pay | $3,172,425 |
|---|---|
| Median Employee's Pay | $245,751 |
| Pay Ratio | 13to 1 |
In 2019, the annual total compensation of David Pernock was $3,172,425.
The annual total compensation of the median employee at Eagle Pharmaceuticals was $245,751.
The ratio of David Pernock's pay to the pay of median employee was therefore 13 to one.
Pernock's colleagues
We found three more compensation records of executives who worked with David Pernock at Eagle Pharmaceuticals in 2019.
News
June 15, 2022
April 30, 2021
April 29, 2020
April 30, 2019